IP Library Granted Patent US 7,629,375
Granted Patent B2
US 7,629,375 · App. 11/015,198 · Granted Dec 8, 2009

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,629,375
App. No.
11/015,198
Granted
Dec 8, 2009
Kind
B2
Abstract

Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituted phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.

Claims (13)

1. A compound of formula A

or formula B

or mixtures and pharmaceutically acceptable salts thereof.

2. A compound as in claim 1 , wherein the compound is of formula A:

and pharmaceutically acceptable salts thereof.

3. A compound as in claim 1 , wherein the compound is of formula B:

and pharmaceutically acceptable salts thereof.

4. A skin care composition comprising a therapeutically effective amount of one or more compounds of claim 1 , further optionally comprising a pharmaceutically or cosmetically acceptable carrier or excipient.

5. The skin care composition of claim 4 , formulated for topical administration to the skin of a mammalian subject.

6. The skin care composition of claim 5 , wherein said composition is included in a topical cosmetic formulation.

7. The skin care composition of claim 5 , wherein said composition is included in a topical pharmaceutical formulation.

8. The skin care composition of claim 4 , formulated for transdermal administration to a mammalian subject.

9. The skin care composition of claim 5 , formulated for oral administration to a mammalian subject.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE MERGED ENTITY' NEW NAME PREVIOUSLY RECORDED AT REEL: 036041 FRAME: 0605. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER & CHANGE OF NAME. Recorded Jul 21, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036143/0449 →
MERGER AND CHANGE OF NAME Recorded Jul 1, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC
Reel/Frame 036041/0605 →
MERGER Recorded Jul 1, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, INC.
To: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC
Reel/Frame 036043/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2006
From: GALILEO PHARMACEUTICALS, INC.
To: JOHNSON & JOHNSON CONSUMER COMPANIES, INC.
Reel/Frame 018407/0725 →
SECURITY AGREEMENT Recorded Dec 22, 2005
From: GALILEO PHARMACEUTICALS, INC.
To: ALLOY VENTURES, INC.
Reel/Frame 016936/0079 →